Eloctate 750 Unit (Antihemophilic Factor (Recombinant Bdd), Fc Fusion Protein KIT) 750 UNIT

ELOCTATE 750 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This intravenous kit helps manage bleeding episodes and prevent surgical bleeding.

Strength

750 UNIT

Pack Size

3ML

Manufacturer / TM Owner

SANOFI-AVENTIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ELOCTATE 750 Unit is primarily used to control and prevent bleeding in patients with hemophilia B, a genetic disorder that affects blood clotting. It is often administered intravenously to manage bleeding episodes or to prevent bleeding during surgical procedures. This medication is designed to replace the missing clotting factor IX, which is essential for proper blood coagulation.

Side Effects

Common effects of ELOCTATE 750 Unit may include mild to moderate reactions at the injection site, such as redness or swelling. Some users may experience flu-like symptoms, including headache, fever, or chills. These effects are generally temporary and should be monitored. Severe allergic reactions are rare but require immediate medical attention.

Precautions & Warnings

ELOCTATE 750 Unit should be handled with care, ensuring proper storage and administration techniques. It is important to follow the instructions provided by a healthcare professional. Patients with known allergies to any components of the medication should avoid its use. Regular monitoring and consultation with a healthcare provider are recommended.

Avoid Interactions

ELOCTATE 750 Unit may interact with certain medications, including those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect blood clotting should be used with caution.

Frequently Asked Questions

ELOCTATE 750 Unit is used to manage and prevent bleeding episodes in patients with hemophilia B.

ELOCTATE 750 Unit is administered intravenously, typically by a healthcare professional.

Common side effects may include mild reactions at the injection site, such as redness or swelling, and flu-like symptoms.

Yes, ELOCTATE 750 Unit can be used to prevent bleeding during surgical procedures in patients with hemophilia B.

Long-term use of ELOCTATE 750 Unit should be monitored by a healthcare provider to ensure safety and effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.